CGRP Inhibitors for Migraine:
What They Are and How They Work
June 1, 2026 • The Headache Lab • 8 min read
Quick Answer
CGRP inhibitors are a newer class of medications specifically designed to target the protein responsible for triggering migraine attacks, offering real relief for patients who haven’t responded to older treatments. Available as monthly injections or oral tablets, they can reduce migraine days by 50% or more. They are one of the most significant advances in migraine medicine in decades.
A New Treatment Option
If you’ve been dealing with migraines for years, you’ve probably tried a lot of things. Maybe some helped a little. Maybe nothing really did. That’s a frustrating place to be, and it’s exactly where a newer class of medications called CGRP inhibitors tends to come up in conversation.
These treatments have genuinely shifted how a lot of providers approach migraine prevention, especially for patients who’ve already burned through the older options without much luck. At The Headache Lab, we’ve seen firsthand how much of a difference they can make for people in Westmont and across Chicagoland who thought they’d run out of roads to try.
So what’s actually going on with these medications? Here’s a straightforward breakdown.
How CGRP Inhibitors Work
There are two main ways these medications block CGRP’s activity:
Monoclonal antibodies latch onto either the CGRP molecule itself or the receptor it tries to bind to, essentially cutting off the signal before it can trigger an attack. Because antibodies stay in the body a long time, a single injection can provide coverage for anywhere from four to twelve weeks.
Gepants are oral medications that block the CGRP receptor too, but their smaller molecular size means they absorb quickly. That makes them useful for stopping a migraine that’s already ramping up, not just preventing future ones.
Whats Available Right Now
On the preventive side, four monoclonal antibodies are currently approved in the U.S.:
- Erenumab (Aimovig): monthly injection, targets the CGRP receptor
- Fremanezumab (Ajovy): monthly or quarterly injection, targets CGRP itself
- Galcanezumab (Emgality): monthly injection, targets CGRP itself
- Eptinezumab (Vyepti): quarterly IV infusion, targets CGRP itself
Gepants give you more flexibility, since several work for both acute and preventive use:
- Ubrogepant (Ubrelvy): acute treatment
- Rimegepant (Nurtec ODT): both acute and preventive
- Atogepant (Qulipta): preventive
For patients who’ve had bad experiences with triptans, or just can’t use them, gepants are often worth a serious look.
You Don’t Have to Manage This Alone
CGRP receptors are a great option for migraine patients who have tried many treatments without finding relief. They are a new class of medications built specifically around how migraines work.
At The Headache Lab, we know migraines affect a lot more than just your head. They disrupt work, relationships, and plans. Our team has helped patients throughout Westmont and the western suburbs of Chicago figure out whether CGRP therapy belongs in their plan, and if so, which approach fits their life.
If you’re still white-knuckling it through attacks on your own, or your current treatment is falling short, it may be time to revisit your options. To schedule an appointment, contact our office. There’s more available today than there was even five years ago, and finding what works starts with a conversation.
Share
Not Sure What Type of Headache You’re Experiencing?
Take our quick migraine quiz to better understand your symptoms and explore possible next steps.
CGRP Inhibitors for Migraine:
What They Are and How They Work
June 1, 2026 • The Headache Lab • 8 min read
A New Treatment Option
If you’ve been dealing with migraines for years, you’ve probably tried a lot of things. Maybe some helped a little. Maybe nothing really did. That’s a frustrating place to be, and it’s exactly where a newer class of medications called CGRP inhibitors tends to come up in conversation.
These treatments have genuinely shifted how a lot of providers approach migraine prevention, especially for patients who’ve already burned through the older options without much luck. At The Headache Lab, we’ve seen firsthand how much of a difference they can make for people in Westmont and across Chicagoland who thought they’d run out of roads to try.
So what’s actually going on with these medications? Here’s a straightforward breakdown.
How CGRP
Inhibitors Work
There are two main ways these medications block CGRP’s activity:
Monoclonal antibodies latch onto either the CGRP molecule itself or the receptor it tries to bind to, essentially cutting off the signal before it can trigger an attack. Because antibodies stay in the body a long time, a single injection can provide coverage for anywhere from four to twelve weeks.
Gepants are oral medications that block the CGRP receptor too, but their smaller molecular size means they absorb quickly. That makes them useful for stopping a migraine that’s already ramping up, not just preventing future ones.
Whats Available Right Now
On the preventive side, four monoclonal antibodies are currently approved in the U.S.:
- Erenumab (Aimovig): monthly injection, targets the CGRP receptor
- Fremanezumab (Ajovy): monthly or quarterly injection, targets CGRP itself
- Galcanezumab (Emgality): monthly injection, targets CGRP itself
- Eptinezumab (Vyepti): quarterly IV infusion, targets CGRP itself
Gepants give you more flexibility, since several work for both acute and preventive use:
- Ubrogepant (Ubrelvy): acute treatment
- Rimegepant (Nurtec ODT): both acute and preventive
- Atogepant (Qulipta): preventive
For patients who’ve had bad experiences with triptans, or just can’t use them, gepants are often worth a serious look.
You Don’t Have to Manage This Alone
CGRP receptors are a great option for migraine patients who have tried many treatments without finding relief. They are a new class of medications built specifically around how migraines work.
At The Headache Lab, we know migraines affect a lot more than just your head. They disrupt work, relationships, and plans. Our team has helped patients throughout Westmont and the western suburbs of Chicago figure out whether CGRP therapy belongs in their plan, and if so, which approach fits their life.
If you’re still white-knuckling it through attacks on your own, or your current treatment is falling short, it may be time to revisit your options. To schedule an appointment, contact our office. There’s more available today than there was even five years ago, and finding what works starts with a conversation.
